Evidence map›Paper›PMID 20974224›Full record

ArticleNeuroscience letters2011

Oral methylphenidate establishes a conditioned place preference in rats.

Thomas E Wooters, Matthew T Walton, Michael T Bardo

Abstract read
In one paragraph

Article in Neuroscience letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas E WootersDepartment of Psychology, University of Kentucky, Lexington, KY 40536-0509, USA.
Matthew T Walton
Michael T Bardo

Funding

Training and Pilot CoreP50DA005312 · NIDA · UNIVERSITY OF KENTUCKY · PI BARDO, MICHAEL T · 1987 to 2016
$19.5M
Development of Novel Therapies or Methamphetamine AbuseR01DA013519 · NIDA · UNIVERSITY OF KENTUCKY · PI DWOSKIN, LINDA P · 2000 to 2009
$5.1M
Reinforcing and neurochemical effects of cocaine in a rodent model of ADHDF31DA023853 · NIDA · UNIVERSITY OF KENTUCKY · PI WOOTERS, THOMAS E · 2008 to 2009
$59k
NIDA NIH HHS F31 DA023853NIDA NIH HHS P50 DA005312NIDA NIH HHS P50 DA05312NIDA NIH HHS R01 DA013519NIDA NIH HHS R01DA13519
6 · The paper itself

Abstract

Emerging data suggest that illicit methylphenidate abuse is a growing problem. Although abuse of the drug typically occurs by the intranasal route, oral (per os; p.o.) methylphenidate also has abuse potential. The present study compared the effects of p.o. and intraperitoneal (i.p.) methylphenidate in rats using the conditioned place preference (CPP) procedure. Young adult male Sprague-Dawley rats were trained to consume oyster crackers injected initially with saline. Next, rats were randomly assigned to receive p.o. or i.p. methylphenidate (3 or 10mg/kg) or saline immediately or 30min prior to 30min conditioning trials. Methylphenidate or saline were each paired 4 times with an end compartment; preference for the methylphenidate-paired compartment was then assessed on a drug-free session. When given immediately prior to conditioning, significant CPP was obtained with both 3 and 10mg/kg of i.p. methylphenidate, but only with 10mg/kg of p.o. methylphenidate. When given 30min prior to conditioning, there was no evidence of CPP for any dose of i.p. or p.o. methylphenidate. These findings are the first demonstration that p.o. methylphenidate has rewarding effects, although i.p. methylphenidate is obtained at a 3mg/kg dose which did not establish CPP with p.o. administration. The lack of CPP following 30min pretreatment also suggests that conditioning may require the CS to be associated with a US of ascending, rather than descending, brain levels of methylphenidate. These results are consistent with clinical evidence of the reduced abuse liability of p.o. methylphenidate relative to methylphenidate taken by other (e.g., intranasal) routes.

Indexed as

Administration, OralAnimalsBrainCentral Nervous System StimulantsConditioning, OperantMaleMethylphenidateMotor ActivityRatsRats, Sprague-DawleyCentral Nervous System StimulantsMethylphenidate

Identifiers

PMID20974224
PMCPMC3010495

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.